ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Regulus Therapeutics Inc

Regulus Therapeutics Inc (RGLS)

1,62
-0,02
(-1,22%)
Fermé 18 Décembre 10:00PM
1,65
0,03
(1,85%)
Après les heures de négociation: 1:26AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1,65
Prix Achat
1,57
Prix Vente
1,66
Volume échangé
397 825
1,53 Fourchette du Jour 1,645
1,08 Plage de 52 semaines 3,78
Cap du marché
Clôture Veille
1,64
Ouverture
1,63
Dernière Transaction
100
@
1.65
(formt)
Dernière heure de transaction
Volume financier
US$ 634 411
VWAP
1,5947
Volume moyen (3 m)
337 398
Actions en circulation
65 500 134
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,53
Bénéfice par action (BPA)
-0,46
Chiffre d'affairess
-
Bénéfice net
-30,04M

À propos de Regulus Therapeutics Inc

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The comp... Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Regulus Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker RGLS. Le dernier cours de clôture d'Regulus Therapeutics était de US$1,64. Au cours de la dernière année, les actions de Regulus Therapeutics ont été négociées dans une fourchette de prix de US$ 1,08 à US$ 3,78.

Regulus Therapeutics compte actuellement 65 500 134 actions en circulation. La capitalisation boursière d'Regulus Therapeutics est de US$107,42 million. Regulus Therapeutics a un ratio cours/bénéfice (ratio PE) de -3.53.

RGLS Dernières nouvelles

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Regulus Therapeutics Inc...

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates PR Newswire SAN DIEGO, Nov. 7, 2024 Completed enrollment in the fourth cohort of the Phase 1b...

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant...

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences PR Newswire SAN DIEGO, Aug. 28, 2024 SAN DIEGO, Aug. 28, 2024 /PRNewswire/ -- Regulus Therapeutics Inc...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.085.095541401271.571.771.523184021.64845194CS
40.2618.70503597121.391.771.32604111.56654751CS
12001.651.81.33373981.54282519CS
26-0.77-31.81818181822.422.591.35105461.81170606CS
520.322.22222222221.353.781.0810950672.23250131CS
1561.3014373.3218588640.34863.780.15767550851.40346749CS
2600.97142.6470588240.683.780.157612323641.20830679CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NUKKNukkleus Inc
US$ 11,655
(738,49%)
174,06M
PRTGPortage Biotech Inc
US$ 8,8678
(172,86%)
36,23M
OPTXSyntec Optics Holdings Inc
US$ 3,55
(99,44%)
92,44M
PTPIPetros Pharmaceuticals Inc
US$ 0,4976
(86,37%)
63,36M
LUXHLuxUrban Hotels Inc
US$ 0,849899
(59,67%)
29,51M
VCNXVaccinex Inc
US$ 1,41
(-61,37%)
758,95k
TNYATenaya Therapeutics Inc
US$ 1,395
(-51,56%)
42,45M
ORKTOrangeKloud Technology Inc
US$ 2,14
(-41,85%)
2,29M
RVPHReviva Pharmaceuticals Holdings Inc
US$ 1,395
(-39,35%)
18,16M
DBGIDigital Brands Group Inc
US$ 2,46
(-37,88%)
805,23k
RIMEAlgorhythm Holdings Inc
US$ 0,0877
(8,27%)
1,13B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,335
(-36,79%)
1,02B
GOEVCanoo Inc
US$ 0,118
(7,08%)
388,43M
NVDANVIDIA Corporation
US$ 130,39
(-1,22%)
259,4M
XTIAXTI Aerospace Inc
US$ 0,0442
(8,33%)
222,55M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock